AAOS endorses imaging guidelines for sarcoma surveillance: 3 things to know

Written by Shayna Korol | September 26, 2018 | Print  |

The American Academy of Orthopaedic Surgeons endorsed the Musculoskeletal Tumor Society's new appropriate use criteria to help physicians determine when to use imaging to monitor bone and soft tissue sarcoma survivors at risk of recurrence.

Here are three things to know:

1. The AUC is accessible through an online tool that rates the appropriateness of certain imaging services depending on patients' indications. The criteria is intended to help physicians minimize the amount of imaging required without jeopardizing surveillance accuracy.

2. The sarcoma surveillance AUC provides standardized best practices for metastatic disease identification and local recurrences given a variety of clinical factors.

3. The tool includes three-month, six-month and one-year intervals.

Click here for the full AUC. The online tool is here.

More articles on imaging:
NuVasive to demonstrate Pulse surgical automation platform: 4 details
Gaucher patients may benefit from multiparametric MRI to help identify & monitor bone lesions, study shows
Kentucky spine center implements Medtronic's Mazor X robotic system for pediatric surgeries: 5 details

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months